Joint Letter to World Health Assembly Delegates | We must delink research and development costs from cancer medicine prices

Response to OECD Online Consultation ‘Sustainable access to innovative therapies’

Statement to the WHO Expert Committee on Selection and Use of Essential Medicines

ACCISS Study Report | Biosimilar Insulin Regulatory Profile

2016 Annual Report & Financial Statements

Report | The Sun Shines on Europe: transparency of financial relationships in the healthcare sector

ACCISS Study Report | Access to Insulin: Current Challenges and Constraints

Position Statement: TACD Positive Consumer Agenda – New Rules for the Global Economy

Media Release: Health Action International start een publiekscampagne tegen stijgende medicijnprijzen

Media Release: Soaring Medicine Prices the Target Of New Public Campaign Ahead Of 15 March Election

Media Statement: European Parliament Hits Target in Recommendations for Improving Access to Medicines

Conference Report: Clinical Drug Trials

Media Release: European Public Health Advocates Demand Greater Public Returns From European Commission’s Research and Development Programme, Horizon 2020

Joint Submission to European Commission Public Consultation on Horizon 2020

HAI Response to the European Commission’s Consultation about EU Cooperation on Health Technology Assessments

Prices and Availability of Locally Produced and Imported Medicines in Ethiopia and Tanzania

Measuring Prices and Availability of Locally-produced and Imported Medicines


Media Release: Insulin Discounts Lower Price Burden for Americans, but Insulin Still Not Affordable Worldwide

Medicines Policy in Moldova

Politica cu privire la medicamente în Republica Moldova

TACD Resolution on Medicinal Products and Medical Devices in the TTIP Agreement

Fact or Fiction? What Healthcare Professionals Need to Know about Pharmaceutical Marketing

Prices and Availability of Locally Produced and Imported Medicines in Ethiopia

Prices and Availability of Locally Produced and Imported Medicines in Tanzania

Health Systems Advocacy Partnership: Fact Sheet

Health Action International Response to Report by Lancet Commission on Essential Medicines

Press Release: Health Action International Receives €460,000 Grant from Dutch Ministry of Foreign Affairs to Fight Snakebite Death & Disability in Sub-Saharan Africa

Press Release: Health Action International Launches Educational Guide to Help EU Healthcare Students & Professionals Counter Ill Effects of Pharmaceutical Marketing

Joint Letter: Civil Society Urges US Secretary Burwell to Expand Access to Patented Cancer Drugs in Developing Countries

Press Release: Report Reveals Danger Of TTIP Locking Europe & Us Into Higher Drug Prices, Failed Pharma Innovation Model